Moderate to Severe Marrow Fibrosis As a More Advanced Risk Factor for MDS and MDS-AML Patients With Excess of Blasts Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Wang, JL; Wang, QQ; Zhang, HX; He, Y; Huang, Y; Zhang, RL; Wei, JL; Ma, QL; Pang, AM; Yang, DL; Chen, X; Jiang, EL; Feng, SZ; Zhai, WH; Han, MZ

Zhai, WH (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol, 288 Nanjing Rd, Tianjin 300020, Peoples R China.

TRANSPLANTATION AND CELLULAR THERAPY, 2021; 27 (8):